Get the Stockscreener App
3.66
1.48%
-0.05
After Hours:
3.66
Clover Health Investments Corp stock is traded at $3.66, with a volume of 3.01M.
It is down -1.48% in the last 24 hours and down -18.60% over the past month.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
See More
Previous Close:
$3.71
Open:
$3.69
24h Volume:
3.01M
Relative Volume:
0.52
Market Cap:
$1.89B
Revenue:
$1.70B
Net Income/Loss:
$-123.70M
P/E Ratio:
-13.74
EPS:
-0.2663
Net Cash Flow:
$-178.21M
1W Performance:
+5.64%
1M Performance:
-18.60%
6M Performance:
+25.60%
1Y Performance:
+314.40%
1-Day Range:
$3.625
$3.76
1-Week Range:
$3.5008
$3.83
52-Week Range:
$0.606
$4.87
Clover Health Investments Corp Stock (CLOV) Company Profile
Name
Clover Health Investments Corp
Sector
Industry
Phone
(201) 432-2133
Address
3401 MALLORY LANE, SUITE 210, FRANKLIN
Compare CLOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
3.66 | 1.89B | 1.70B | -123.70M | -178.21M | -0.2663 |
|
UNH
Unitedhealth Group Inc
|
511.30 | 467.54B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
434.28 | 97.87B | 176.81B | 5.98B | 4.55B | 25.61 |
|
CI
Cigna Group
|
321.39 | 86.98B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
68.64 | 85.62B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
266.83 | 32.27B | 117.76B | 1.21B | 2.39B | 9.95 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Initiated | Craig Hallum | Buy |
| Oct-07-24 | Initiated | UBS | Neutral |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Feb-02-22 | Upgrade | Cowen | Underperform → Market Perform |
| Jan-19-22 | Initiated | SVB Leerink | Mkt Perform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Jan-07-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-10-21 | Initiated | Cowen | Underperform |
| Sep-02-21 | Resumed | Citigroup | Neutral |
| Jul-12-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| May-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Feb-02-21 | Initiated | Citigroup | Buy |
| Feb-01-21 | Initiated | JP Morgan | Neutral |
View All
Clover Health Investments Corp Stock (CLOV) Latest News
Is Clover Health Investments (CLOV) the Best Stock to Invest in for a Stock Market Game? - Insider Monkey
12 Best Stocks to Invest in for a Stock Market Game - Insider Monkey
3 Promising Penny Stocks With Market Caps Over $1B - Simply Wall St
Is Clover Health Investments, Corp. (CLOV) the Best Multibagger Stock to Buy in 2025? - Insider Monkey
Clover Health director sells $722,000 in stock - Investing.com India
Clover Health director sells $722,000 in stock By Investing.com - Investing.com Australia
12 Best Multibagger Stocks to Buy in 2025 - Insider Monkey
Clover Health at Leerink Global Healthcare: Tech-Driven Medicare Growth - Investing.com
Clover Health general counsel sells $199,500 in stock By Investing.com - Investing.com Australia
Clover Health’s CEO of home care sells $276,000 in stock By Investing.com - Investing.com Australia
Missed the Hims & Hers Rally? Clover Health Could Be Next - MSN
Insider Moves: Clean Energy, Warner Bros, Clover Health, Corning, TJX - TipRanks
Clover Health’s CEO of home care sells $276,000 in stock - Investing.com
Clover Health general counsel sells $199,500 in stock - Investing.com
After ‘Really Good’ Year, Insurtechs Look to Continue Growth in 2025 - MMITNetwork
Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth - Seeking Alpha
Decoding Clover Health Investments Corp (CLOV): A Strategic SWOT Insight - GuruFocus.com
Canaccord lifts Clover Health stock target to $4.50, maintains buy By Investing.com - Investing.com Australia
Clover Health’s Earnings Call Highlights Profitability and Growth - TipRanks
Clover Health Investments (NASDAQ:CLOV) Given New $4.50 Price Target at Canaccord Genuity Group - Defense World
Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians - The Manila Times
Can This Google Cloud Partnership Help Clover Health Solve the 28-Hour Administrative Burden Crushing Doctors? - StockTitan
Canaccord lifts Clover Health stock target to $4.50, maintains buy - Investing.com
CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-K Report - TradingView
Clover Health Investments (NASDAQ:CLOV) Releases Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Clover Health Investments (NASDAQ:CLOV) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Clover Health Investments (CLOV) to Release Quarterly Earnings on Thursday - MarketBeat
Clover Health Reports Q4 2024 Revenue of $337 Million, Missing E - GuruFocus.com
Clover Health Investments CorpOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire
CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises - Nasdaq
Clover Health Investments Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Clover Health Investments, Corp. (CLOV) Tops Q4 Earnings Estimates - MSN
Clover Health Investments, Corp. (NASDAQ:CLOV) Q4 2024 Earnings Call Transcript - Insider Monkey
Clover Health Investments, Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Clover Health Investments Corp (CLOV) Q4 2024 Earnings Call High - GuruFocus.com
Clover Health Investments Corp (CLOV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance
Clover Health Investments Corp (CLOV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada
Clover Health Reports Improved 2024 Financial Results - TipRanks
Earnings call transcript: Clover Health’s Q4 2024 results beat EPS expectations - Investing.com India
Earnings call transcript: Clover Health’s Q4 2024 results beat EPS expectations By Investing.com - Investing.com South Africa
Clover Health Investments earnings beat by $0.03, revenue fell short of estimates By Investing.com - Investing.com
Clover Health Q4 Loss Narrows, Revenue Rises -February 27, 2025 at 05:41 pm EST - Marketscreener.com
Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance - The Manila Times
From Losses to Profits: How Clover Health Turned Around Its Financials and What's Next - StockTitan
Clover Health (NASDAQ:CLOV) Reports Sales Below Analyst Estimates In Q4 Earnings - Yahoo Finance
Clover Health Investments Corp Stock (CLOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clover Health Investments Corp Stock (CLOV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Priest Brady Patrick | CEO of Home Care |
Mar 06 '25 |
Sale |
3.68 |
75,000 |
276,000 |
2,418,151 |
| Soares Karen | General Counsel & Secretary |
Mar 06 '25 |
Sale |
3.80 |
52,500 |
199,500 |
1,299,663 |
0.39%
2.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):